Body-Composition Research The GH/IGF-1 axis is closely related to body composition, including lean tissue signaling, lipid metabolism, tissue remodeling, and age-related changes in the somatotropic axis. Research on GHRH analogs, including sermorelin-related compounds, has explored effects on GH pulses, IGF-1, and lean-to-fat ratio in older adults. These findings do not directly prove body-composition benefits for all forms of CJC-1295, but they support the broader rationale for studying GHRH analogs in this area
To further increase knowledge about the potential protective mechanism of GLP-1 RA, the mechanistic REMODEL trial (NCT04865770) is underway to further investigate these potential pathways [61]
Anxiety related to GLP-1 medications is a recognized phenomenon, and the added uncertainty of cycling between medications can amplify these feelings
10.1016/0306-4522(88)90182-0 22 BraszkoJ
To maintain consistent results, each dose should be scheduled on the same day of the week as the first treatment
ArticlePubMed 35